We use some essential cookies to make this website work.
We’d like to set additional cookies to understand how you use GOV.UK, remember your settings and improve government services.
We also use cookies set by other sites to help us deliver content from their services.
You have accepted additional cookies. You can change your cookie settings at any time.
You have rejected additional cookies. You can change your cookie settings at any time.
Departments, agencies and public bodies
News stories, speeches, letters and notices
Detailed guidance, regulations and rules
Reports, analysis and official statistics
Consultations and strategy
Data, Freedom of Information releases and corporate reports
The Scientific Advisory Committee on Nutrition (SACN) report on saturated fats and health.
The UK Government has announced its intent to pursue an innovative new collaboration to tackle heart disease with pharmaceutical company Novartis
A systematic audit within the Medway Clinical Commissioning Group significantly increased recorded prevalence of FH
People are urged to use the updated tool to find out their heart age and their risk of heart attack and stroke this World Heart Day.
Professor John Deanfield, CBE announced as the first ever Government Champion for Personalised Prevention.
National Heart Month 2016: new research shows a discrepancy between how much men value their health, and what they do to look after it.
Public Health England and NHS England lead coalition of over 40 organisations to step up fight against the nation’s biggest killer.
Statins (HMG-CoA reductase inhibitors) are widely used medicines for patients with lipid disorders and in the primary and secondary prevention of heart attack and stroke.
The maximum recommended dose for simvastatin in conjunction with amlodipine and diltiazem is now 20 mg/day.
A programme involving multiple interventions to improve the cardiovascular health of Bradford’s residents and reduce CVD-related deaths.
Health commissioners can use the new return on investment tool to help decide the best approach to preventing cardiovascular disease within their populations.
Increased risk of stroke in older women should be taken into account in prescribing decisions.
There is an increased risk of myopathy associated with high-dose (80 mg) simvastatin. The 80-mg dose should be considered only in patients with severe hypercholesterolaemia and high risk of cardiovascular complications who have not achieved their treatment goals on lower...
Statin use may be associated with a level of hyperglycaemia in some patients where formal diabetes care is appropriate.
Today, the Department of Health published the combined results from the first three years of the National Diet and Nutrition Survey (NDNS) rolling…
First published during the 2010 to 2015 Conservative and Liberal Democrat coalition government
Don’t include personal or financial information like your National Insurance number or credit card details.
To help us improve GOV.UK, we’d like to know more about your visit today. Please fill in this survey (opens in a new tab).